Cochlear Limited (ASX: COH) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Cochlear Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Cochlear Limited (ASX: COH)
    Latest News

    a woman
    ⏸️ Investing

    The stock picker's guide to Cochlear Limited

    What do investors need to be aware of before the company’s interim results?

    Read more »

    a woman
    ⏸️ Investing

    4 things you need to know about Cochlear

    The competitive advantages that Cochlear enjoys should almost certainly result in solid and sustainable earnings growth.

    Read more »

    a woman
    ⏸️ Investing

    Aussie dollar falls to 3.5-year low

    Which companies will benefit as it continues its fall?

    Read more »

    ⏸️ Investing

    10 top companies for US Dollar exposure in 2014

    A lower Australian dollar will help medical and mining companies most.

    Read more »

    ⏸️ Investing

    5 stocks for five years

    Can these five stocks beat the market over five years?

    Read more »

    a woman
    ⏸️ Investing

    Aussie dollar falls as US quantitative easing ends

    Aussie drops below 93 US cents as US Federal Reserve set to end quantitative easing by mid-2014

    Read more »

    Frequently Asked Questions

    Yes, Cochlear Ltd has historically paid two fully franked dividends a year.

    Cochlear Ltd generally pays its dividends in April and October. 

    Cochlear Ltd listed on the ASX on 4 December 1995.

    COH ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Cochlear Limited

    Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.

    The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.

    Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.

    Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.

     

    Profile

    since

    Note